GNAO1 mutation-related severe involuntary movements treated with gabapentin.
Akasaka M, Kamei A, Tanifuji S, Asami M, Ito J, Mizuma K, Oyama K, Tokutomi T, Yamamoto K, Fukushima A, Takenouchi T, Uehara T, Suzuki H, Kosaki K.
Akasaka M, et al. Among authors: ito j.
Brain Dev. 2021 Apr;43(4):576-579. doi: 10.1016/j.braindev.2020.12.002. Epub 2020 Dec 23.
Brain Dev. 2021.
PMID: 33358199